Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.78−0.09 (-1.85%)
Close on Nov 18, 2026Market cap $789.85MP/E 6.2Yield –
Ironwood Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ironwood Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was $185.56M, up 518.8% year over year. For fiscal 2025 it was $127.04M, up 22.7% from the year before. The highest annual figure on record is $273.76M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.04M | +22.7% |
| FY2024 | Dec 31, 2024 | $103.55M | -43.5% |
| FY2023 | Dec 31, 2023 | $183.43M | -33.0% |
| FY2022 | Dec 31, 2022 | $273.76M | +4.5% |
| FY2021 | Dec 31, 2021 | $261.90M | +55.1% |
| FY2020 | Dec 31, 2020 | $168.84M | +1474.2% |
| FY2019 | Dec 31, 2019 | $10.73M | – |
| FY2018 | Dec 31, 2018 | -$70.88M | – |
| FY2017 | Dec 31, 2017 | -$100.75M | – |
| FY2016 | Dec 31, 2016 | -$25.93M | – |
| FY2015 | Dec 31, 2015 | -$106.93M | – |
| FY2014 | Dec 31, 2014 | -$155.57M | – |
| FY2013 | Dec 31, 2013 | -$273.36M | – |
| FY2012 | Dec 31, 2012 | -$69.63M | – |
| FY2011 | Dec 31, 2011 | -$75.24M | – |
| FY2010 | Dec 31, 2010 | -$67.90M | – |
| FY2009 | Dec 31, 2009 | -$3.45M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $58.28M | – |
| Q1 FY2026 | Mar 31, 2026 | $5.12M | -74.3% |
| Q4 FY2025 | Dec 31, 2025 | $74.58M | +390.2% |
| Q3 FY2025 | Sep 30, 2025 | $47.58M | +381.4% |
| Q2 FY2025 | Jun 30, 2025 | -$15.07M | -145.0% |
| Q1 FY2025 | Mar 31, 2025 | $19.95M | -55.6% |
| Q4 FY2024 | Dec 31, 2024 | $15.21M | -57.5% |
| Q3 FY2024 | Sep 30, 2024 | $9.89M | -69.5% |
| Q2 FY2024 | Jun 30, 2024 | $33.47M | -4.3% |
| Q1 FY2024 | Mar 31, 2024 | $44.99M | -43.9% |
| Q4 FY2023 | Dec 31, 2023 | $35.83M | -54.7% |
| Q3 FY2023 | Sep 30, 2023 | $32.46M | -53.0% |
| Q2 FY2023 | Jun 30, 2023 | $34.96M | -43.0% |
| Q1 FY2023 | Mar 31, 2023 | $80.17M | +25.0% |
| Q4 FY2022 | Dec 31, 2022 | $79.18M | +22.6% |
| Q3 FY2022 | Sep 30, 2022 | $69.09M | -8.0% |
| Q2 FY2022 | Jun 30, 2022 | $61.37M | +26.3% |
| Q1 FY2022 | Mar 31, 2022 | $64.12M | -13.0% |
| Q4 FY2021 | Dec 31, 2021 | $64.57M | +25.3% |
| Q3 FY2021 | Sep 30, 2021 | $75.07M | +40.0% |
| Q2 FY2021 | Jun 30, 2021 | $48.57M | +141.8% |
| Q1 FY2021 | Mar 31, 2021 | $73.69M | +69.0% |
| Q4 FY2020 | Dec 31, 2020 | $51.51M | +86.8% |
| Q3 FY2020 | Sep 30, 2020 | $53.63M | +54.3% |
| Q2 FY2020 | Jun 30, 2020 | $20.09M | – |
| Q1 FY2020 | Mar 31, 2020 | $43.60M | – |
| Q4 FY2019 | Dec 31, 2019 | $27.58M | +197.4% |
| Q3 FY2019 | Sep 30, 2019 | $34.77M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.24M | – |
| Q1 FY2019 | Mar 31, 2019 | -$42.39M | – |
| Q4 FY2018 | Dec 31, 2018 | $9.27M | – |
| Q3 FY2018 | Sep 30, 2018 | -$26.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$22.69M | – |
| Q1 FY2018 | Mar 31, 2018 | -$30.89M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.21M | – |
| Q3 FY2017 | Sep 30, 2017 | -$31.24M | – |
| Q2 FY2017 | Jun 30, 2017 | -$32.45M | – |
| Q1 FY2017 | Mar 31, 2017 | -$27.85M | – |
| Q4 FY2016 | Dec 31, 2016 | -$19.19M | – |
| Q3 FY2016 | Sep 30, 2016 | -$645.00K | – |
See a number that looks wrong?